Skip to main content
Retour
Watch Compare

NRX Pharmaceuticals, Inc.

Qualité des données : 100%
Également cotée sous NRXPW NASDAQ
NRXP
NASDAQ Manufacturing Chemicals
2,22 €
0,00 € (0,00%)
Cap. Boursière: 74,73 M
Prix
2,26 €
Cap. Boursière
74,73 M
Fourchette du Jour
—
Fourchette 52 Semaines
—
Volume
—
Ouverture —
Moyenne 50J / 200J
—
Moyenne 50J / 200J
—

Quick Summary

Points Clés

Negative free cash flow of -14,11 M

Croissance

Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Qualité

Return on Equity
N/A
ROICN/A
Net Margin-2336,49%
Op. Margin-1324,41%

Sécurité

Debt / Equity
N/A
Current Ratio0,15
Interest Coverage-24,18

Valorisation

PE (TTM|NTM|2027)
-2,61 | 0,56 | 0,58
En dessous de la moyenne du secteur (-1,49)
P/B RatioN/A
EV/EBITDAN/A
Dividend YieldN/A

Historique des Prix

Tendances Financières

Comparaison Sectorielle

vs médiane du secteur Manufacturing (1385 pairs)
Métrique Action Médiane du Secteur
P/E -2,6 -1,5
P/B — 1,6
ROE % — -54,0
Net Margin % -2336,5 -41,5
Rev Growth 5Y % — 1,8
D/E — 0,3

Objectif de Cours des Analystes

4 analystes
Buy
Actuel
2,22 €
+1611.7%
Objectif
38,00 €
25,00 €
39,50 €
48,00 €
Prévisions
P/E Prévisionnel 0,56
BPA Prévisionnel 3,93 €
Croissance BPA (est.) +2923,1%
CA Est. 537,97 M

Estimations de Bénéfices

Période BPA Est. CA Est. Analystes
FY2027 3,93 €
1,23 € – 6,63 €
 537,97 M 2
FY2026 0,13 €
0,13 € – 0,13 €
 110,09 M 1

Surprises de Résultats

Derniers 4 trimestres
Trimestre BPA Est. BPA Réel Surprise
Q42025 -0,08 € 0,18 € +329,1%
Q32025 -0,02 € -0,51 € -2938,4%
Q22025 -0,23 € -0,98 € -326,1%
Q12025 -0,25 € -0,34 € -36,0%

ETFs Holding This Stock

PSIL logo PSIL AdvisorShares Psychedelics ETF
6,59% weight

All Fundamental Metrics
Growth
Revenue Growth (1Y) N/A Revenue Growth (3Y) N/A
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) 1,23 M Net Income (TTM) -28,62 M
ROE N/A ROA -783,95%
Gross Margin N/A Operating Margin -1324,41%
Net Margin -2336,49% Free Cash Flow (TTM) -14,11 M
ROIC N/A FCF Growth (3Y) N/A
Safety
Debt / Equity N/A Current Ratio 0,15
Interest Coverage -24,18 Asset Turnover 0,34
Working Capital -18,56 M Tangible Book Value -23,22 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -2,61 Forward P/E 0,56
P/B Ratio N/A P/S Ratio 61,01
PEG Ratio N/A Forward PEG 0,00
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S 0,14 Fwd Earnings Yield 178,57%
FCF Yield -18,88%
Market Cap 74,73 M Enterprise Value 73,29 M
Per Share
EPS (Diluted TTM) N/A Revenue / Share 0,04
FCF / Share -0,43 OCF / Share -0,43
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue N/A FCF Conversion 49,30%
SBC-Adj. FCF -14,91 M Growth Momentum N/A

Income Statement

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue 1,23 M 0,0 — — —
Net Income -28,62 M -25,13 M -30,15 M -39,75 M -93,06 M
EPS (Diluted) — — — -0,60 -1,98
Gross Profit — — — — —
Operating Income -16,22 M -18,50 M -27,84 M -44,34 M -115,80 M
EBITDA — — — — —
R&D Expenses 3,78 M 6,20 M 13,37 M 17,03 M 20,26 M
SG&A Expenses 13,06 M — — — —
D&A 70 000,0 — — — —
Interest Expense 671 000,0 230 000,0 120 000,0 18 000,0 18 000,0
Income Tax 0,0 0,0 — — —

Balance Sheet

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 12,96 M 3,65 M 7,32 M 25,82 M 32,73 M
Total Liabilities 28,89 M 26,87 M 19,05 M 18,41 M 11,92 M
Shareholders' Equity -15,94 M -23,22 M -11,73 M 7,41 M 20,81 M
Total Debt — — 9,16 M — —
Cash & Equivalents 7,80 M 1,44 M 4,60 M 20,05 M —
Current Assets 8,89 M 3,30 M 6,88 M 25,80 M 32,71 M
Current Liabilities 28,58 M 21,86 M 19,05 M 15,59 M 11,92 M